The Scientist

» pharmaceuticals and culture

Most Recent

image: Thermo Fisher to Acquire Affymetrix

Thermo Fisher to Acquire Affymetrix

By | January 11, 2016

The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.

0 Comments

image: Speaking of Science

Speaking of Science

By | January 1, 2016

January 2016's selection of notable quotes

0 Comments

image: Speaking of Science 2015

Speaking of Science 2015

By | December 31, 2015

A year’s worth of noteworthy quotes

0 Comments

image: Bayer Enters CRISPR Field

Bayer Enters CRISPR Field

By | December 22, 2015

The pharmaceutical company will spend $335 million on a new venture with biotech startup CRISPR Therapeutics.

0 Comments

image: First Dengue Vax Approved

First Dengue Vax Approved

By | December 11, 2015

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | December 1, 2015

Welcome to the Microbiome, The Paradox of Evolution, Newton's Apple, and Dawn of the Neuron.

0 Comments

image: Self Correction

Self Correction

By | December 1, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: Daraprim Discounts Offered

Daraprim Discounts Offered

By | November 26, 2015

Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.

0 Comments

image: Agar Shortage Limits Lab Supplies

Agar Shortage Limits Lab Supplies

By | November 24, 2015

One large provider says the shortfall should clear up by early 2016.

1 Comment

image: Pfizer and Allergan to Merge

Pfizer and Allergan to Merge

By | November 23, 2015

The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS